Atlas Trials

Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)

Clinical trial NCT06300476 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06300476
Sponsor
West China Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Stargardt Disease 1
Start date
2023-11-20
Primary completion
2026-12-30
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.